JP2024520815A5 - - Google Patents

Info

Publication number
JP2024520815A5
JP2024520815A5 JP2023575918A JP2023575918A JP2024520815A5 JP 2024520815 A5 JP2024520815 A5 JP 2024520815A5 JP 2023575918 A JP2023575918 A JP 2023575918A JP 2023575918 A JP2023575918 A JP 2023575918A JP 2024520815 A5 JP2024520815 A5 JP 2024520815A5
Authority
JP
Japan
Prior art keywords
aav
sequence
seq
item
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575918A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032679 external-priority patent/WO2022261209A1/en
Publication of JP2024520815A publication Critical patent/JP2024520815A/ja
Publication of JP2024520815A5 publication Critical patent/JP2024520815A5/ja
Pending legal-status Critical Current

Links

JP2023575918A 2021-06-08 2022-06-08 神経線維腫性障害を処置するための組成物および方法 Pending JP2024520815A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163202359P 2021-06-08 2021-06-08
US63/202,359 2021-06-08
PCT/US2022/032679 WO2022261209A1 (en) 2021-06-08 2022-06-08 Compositions and methods for treating neurofibromatic disorders

Publications (2)

Publication Number Publication Date
JP2024520815A JP2024520815A (ja) 2024-05-24
JP2024520815A5 true JP2024520815A5 (cg-RX-API-DMAC7.html) 2025-06-17

Family

ID=84425523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575918A Pending JP2024520815A (ja) 2021-06-08 2022-06-08 神経線維腫性障害を処置するための組成物および方法

Country Status (5)

Country Link
US (1) US20230056226A1 (cg-RX-API-DMAC7.html)
EP (1) EP4352079A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024520815A (cg-RX-API-DMAC7.html)
CN (1) CN117813314A (cg-RX-API-DMAC7.html)
WO (1) WO2022261209A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024515629A (ja) * 2021-04-14 2024-04-10 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル ニューロフィブロミン2/マーリン(nf2)遺伝子療法のための材料及び方法
WO2025054256A1 (en) * 2023-09-06 2025-03-13 Tenaya Therapeutics, Inc. Targeting peptides, engineered aav capsid proteins and virions
CN118291543A (zh) * 2024-02-29 2024-07-05 神拓生物技术(杭州)有限公司 一种二型神经纤维瘤基因治疗的慢病毒载体及其应用
WO2025205770A1 (ja) * 2024-03-26 2025-10-02 国立大学法人 東京大学 スタッファーdnaを含む組換えプラスミド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707863A (en) * 1993-02-25 1998-01-13 General Hospital Corporation Tumor suppressor gene merlin
EP1668143B1 (en) * 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
CA2840211A1 (en) * 2011-06-28 2013-01-03 Glaxosmithkline Intellectual Property (No.2) Limited Method of administration and treatment
WO2015171270A1 (en) * 2014-05-06 2015-11-12 Felder Mitchell S Method for the treatment of neurofibromatosis
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
WO2017191274A2 (en) * 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein
AU2019300431A1 (en) * 2018-07-13 2021-01-14 Ucl Business Ltd Glucocerebrosidase gene therapy
JP2024515629A (ja) * 2021-04-14 2024-04-10 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル ニューロフィブロミン2/マーリン(nf2)遺伝子療法のための材料及び方法

Similar Documents

Publication Publication Date Title
JP7324253B2 (ja) 補体媒介性疾患を処置するための組成物及び方法
JP6879486B2 (ja) Fviiiおよびfix用の最適化された肝臓特異的発現系
JP2025000642A5 (cg-RX-API-DMAC7.html)
RU2018143411A (ru) Лечение комплемент-опосредуемых расстройств
BR112021012048A2 (pt) Fator complementar i e cofator de fator complementar i, vetores que codificam os mesmos e uso terapêutico
US20250002546A1 (en) Vectors for Increasing NPRL2 Expression in Cancer Cells and Methods of Use Thereof
WO2022081776A1 (en) Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
JP2024520815A (ja) 神経線維腫性障害を処置するための組成物および方法
CN115927412A (zh) 密码子优化的补体因子i
KR20260005328A (ko) 항vegf 단백질을 코딩하는 핵산, 폴리뉴클레오타이드 발현 카세트 및 재조합 아데노 관련 바이러스
EP4509606A1 (en) Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof
JP2023526892A (ja) バルデー・ビードル症候群の遺伝子治療
KR102814185B1 (ko) 라포라병을 예방 또는 치료하기 위한 재조합 아데노 연관 바이러스 및 이를 포함하는 약학적 조성물
HK40086178A (en) Composition and method for treating complement-mediated disease
WO2026055191A1 (en) Methods and compositions for treating glioblastoma
KR20250080845A (ko) 라포라병을 예방 또는 치료하기 위한 재조합 아데노 연관 바이러스 및 이를 포함하는 약학적 조성물
TW202516019A (zh) 具中樞神經系統靶向模體的突變aav及含有其之組成物
BR112018005684B1 (pt) Vetor viral recombinante, composição farmacêutica e seus usos